Wei Zhao

10.2k total citations · 1 hit paper
276 papers, 4.2k citations indexed

About

Wei Zhao is a scholar working on Pharmacology, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wei Zhao has authored 276 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pharmacology, 83 papers in Epidemiology and 60 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wei Zhao's work include Antibiotics Pharmacokinetics and Efficacy (81 papers), Pharmaceutical studies and practices (39 papers) and Pneumonia and Respiratory Infections (33 papers). Wei Zhao is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (81 papers), Pharmaceutical studies and practices (39 papers) and Pneumonia and Respiratory Infections (33 papers). Wei Zhao collaborates with scholars based in China, France and United States. Wei Zhao's co-authors include Évelyne Jacqz-Aigrain, May Fakhoury, Stéphanie Leroux, Valérie Biran, M. D. Ginsberg, W. Dalton Dietrich, Thomas Storme, Georges Deschênes, Daolun Zhang and Raul Busto and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Zhao

257 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment

2025 16 citations Wei Zhao et al. profile →

Peers

Countries citing papers authored by Wei Zhao

Since Specialization

Citations

This map shows the geographic impact of Wei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhao more than expected).

Fields of papers citing papers by Wei Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhao. The network helps show where Wei Zhao may publish in the future.

Co-authorship network of co-authors of Wei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zhao. A scholar is included among the top collaborators of Wei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zhao. Wei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Revealing the gas sensing enhancement mechanism of NiO/WO3 bilayer gas sensors to triethylamine via GC–MS 2025 ·Microchemical Journal ·Kuan Tian, (unknown), Wei Zhao, Zhenxing Li, Yajie Zheng, Zhenzhen Dong, (unknown), Yuan Sun, Pengcheng Xu	4
2	Sialidase NEU3 silencing inhibits angiogenesis of EA.hy926 cells by regulating Wnt/β-catenin signaling pathway 2024 ·Biochemical and Biophysical Research Communications ·(unknown), Xin Yuan, (unknown), Fang Ma, Wei Zhao, (unknown), Xue Ma, (unknown)	0
3	GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma 2024 ·Pharmacological Research ·(unknown), Fei Xie, Xiaohu Wen, (unknown), Ruping Zhao, (unknown), Han Li, Yanqi Li, (unknown), Chen Liu, Yi Yang, Pengxiang Zhao, Boqing Wang, Wei Zhao, (unknown)	9
4	Allergy in perioperative setting 2024 ·SHILAP Revista de lepidopterología ·Wei Zhao	2
5	Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future 2024 ·Advanced Drug Delivery Reviews ·(unknown), Yuanyuan Zheng, Qiu‐Yue Li, (unknown), (unknown), Huixin Liu, Guo‐Xiang Hao, John van den Anker, (unknown), Wei Zhao	1
6	Safety and efficacy of endovascular recanalization for symptomatic non-acute atherosclerotic intracranial large artery occlusion 2023 ·Frontiers in Neurology ·Xi Chu, (unknown), Jun Zhang, (unknown), (unknown), (unknown), (unknown), Yun Song, Meimei Zheng, Wei Wang, Wei Zhao, Ju Han	5
7	Pharmacokinetics and bioavailability of a new long-acting insulin analog in healthy Chinese volunteers: an open, randomized, single-dose, two-period and two-sequence cross-over study 2023 ·Frontiers in Pharmacology ·(unknown), Yehui Zhang, Panpan Ye, (unknown), Linlin Song, (unknown), Qian Li, (unknown), (unknown), (unknown), Kai Shen, Sheng Feng, Wei Zhao	0
8	Recombinant Klotho alleviates vancomycin-induced acute kidney injury by upregulating anti-oxidative capacity via JAK2/STAT3/GPx3 axis 2023 ·Toxicology ·Mengmeng Wang, Yue Zhou, Guo‐Xiang Hao, (unknown), Rui Yin, Yihao Zheng, Wei Zhao	8
9	Meropenem Clearance in a Child With End-stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy: A Case Report and Literature Review 2023 ·The Pediatric Infectious Disease Journal ·(unknown), Wei Zhang, Wei Cao, John van den Anker, Xiaoyu Chen, Wei Zhao	0
10	Predictive Performance of Pharmacokinetic Model-Based Virtual Trials of Vancomycin in Neonates: Mathematics Matches Clinical Observation 2022 ·Clinical Pharmacokinetics ·(unknown), Yue‐E Wu, Bo‐Hao Tang, Guo‐Xiang Hao, Évelyne Jacqz-Aigrain, John van den Anker, Wei Zhao	3
11	MethBank 4.0: an updated database of DNA methylation across a variety of species 2022 ·Nucleic Acids Research ·Mochen Zhang, Wenting Zong, Dong Zou, Guo‐Liang Wang, Wei Zhao, (unknown), Song Wu, Xinran Zhang, (unknown), Yingke Ma, Zhuang Xiong, Zhang Zhang, Yīmíng Bào, Rujiao Li	9
12	Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia 2021 ·Drug Design Development and Therapy ·Li Zhang, (unknown), Jing Chen, Lei Hu, Fan Yang, Yue Zhou, Beibei Zhao, Wei Zhao, Xiaofan Zhu	9
13	Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper 2021 ·British Journal of Clinical Pharmacology ·Anne Smits, Pieter Annaert, Giacomo Cavallaro, Pieter De Cock, Saskia N. de Wildt, Jenny M. Kindblom, Florian B. Lagler, Carmen Moreno, Pavla Pokorná, Michiel F. Schreuder, Joseph F. Standing, M. Turner, Benedetto Vitiello, Wei Zhao, (unknown), Raffaella Willmann, John van den Anker, Karel Allegaert	30
14	Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants 2020 ·The Journal of Clinical Pharmacology ·Yue‐E Wu, Yakun Wang, Bo‐Hao Tang, Lei Dong, L. Xue, Wei Zhang, (unknown), (unknown), John van den Anker, (unknown), Wei Zhao	6
15	Extremely low dose of 6‐mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations 2020 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Yue Zhou, Lei Dong, (unknown), (unknown), Évelyne Jacqz-Aigrain, Tianyou Wang, Li Wang, Wei Zhao	0
16	Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration 2020 ·Pharmaceutical Research ·Yue Zhou, Bin Du, Min‐Yen Kan, Shang Chen, Bo‐Hao Tang, (unknown), Panpan Ye, (unknown), Guo‐Xiang Hao, Xiuli Guo, Qiuju Han, Yi Zheng, Wei Zhao	7
17	<p>Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children</p> 2019 ·Drug Design Development and Therapy ·Qian Li, Kai Wang, Haiyan Shi, Yue‐E Wu, Yue Zhou, Min‐Yen Kan, Yi Zheng, Guo‐Xiang Hao, (unknown), Yilei Yang, (unknown), Xiao‐Ling Wang, Évelyne Jacqz-Aigrain, (unknown), Wei Zhao	3
18	Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats 2018 ·Journal of Endocrinology ·Min Hu, Yuehui Zhang, (unknown), (unknown), Jiao Zhang, Wei Zhao, (unknown), Juan Li, (unknown), Peng Cui, Xin Li, Xiaoke Wu, Mats Brännström, Ruijin Shao, Håkan Billig	34
19	Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study 2018 ·Archives of Disease in Childhood ·Dongfeng Zhang, Guo‐Xiang Hao, (unknown), (unknown), Fujuan Liu, Ling Liu, Xiao‐Ying Yuan, Ruihong Li, (unknown), Qian Dong, Évelyne Jacqz-Aigrain, Wei Zhao	14
20	Population pharmacokinetics of tacrolimus in children with nephrotic syndrome 2018 ·British Journal of Clinical Pharmacology ·Guo‐Xiang Hao, Xin Huang, Dongfeng Zhang, Yi Zheng, (unknown), Yan Li, Évelyne Jacqz-Aigrain, Wei Zhao	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact